Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
Titel:
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
Auteur:
Douillard, J.Y. Siena, S. Cassidy, J. Tabernero, J. Burkes, R. Barugel, M. Humblet, Y. Bodoky, G. Cunningham, D. Jassem, J. Rivera, F. Kocákova, I. Ruff, P. Błasińska-Morawiec, M. Šmakal, M. Canon, J.L. Rother, M. Oliner, K.S. Tian, Y. Xu, F. Sidhu, R.